Intriguingly, it has been reported that a survivin minigene DNA vaccine is effective to suppress tumor growth and metastasis in a syngeneic NB mouse model [185], providing a promising approach to the development of a novel therapeutic strategy against NB. The gene discussed is BIRC5; the disease is neoplasm.